BAYER PHARMA AG and arGEN-X announced a collaboration to develop therapeutic antibodies.
ELI LILLY AND COMPANY and Qiagen N.V. announced a plan to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types.
DANA-FARBER CANCER INSTITUTE and Trovagene Inc. entered into a clinical collaboration to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.
YESHIVA UNIVERSITY and Montefiore Health System agreed to have Montefiore assume greater responsibility for the day-to-day operations and financial management of Albert Einstein College of Medicine, with Yeshiva remaining the degree-granting institution.
HIROMITSU OTA received the 2014 Ching Jer Chern Memorial Award from The Wistar Institute.
SANDEEP REDDY was named chief medical officer of Caris Life Sciences.
PATRICIA LORUSSO was named associate director of innovative medicine at Yale Cancer Center. She will take the job in August, and will also serve as a professor of medicine.
CORINNE AUGELLI-SZAFRAN was named director of chemistry at Southern Research Institute.
THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, the World Health Organization, and the International Association of Cancer Registries developedguidelines for establishing cancer registriesfor low- and middle-income countries.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGYreleased a compendium of practice tools and resources to help oncologists develop high-qualitycancer survivorship care programsand improve their existing programs for patients who have completed curative treatment or who have transitioned to maintenance or prophylactic therapy.
